Medpace Holdings (MEDP) Tops Q4 EPS by 49c, Beats on Revenue; Offers FY26 Revenue Guidance

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $4.67, $0.49 better than the analyst estimate of $4.18. Revenue for the quarter came in at $708.5 million versus the consensus estimate of $689.34 million.

GUIDANCE:

Medpace Holdings sees FY2026 revenue of $2.76-2.86 billion, versus the consensus of $2.81 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Nakamoto closes healthcare clinics, completes shift to Bitcoin
• Guardian Pharmacy names new COO and CFO, effective July 2026